Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Go back to Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update| (NASDAQ: ORKA) | Delayed: 85.58 +0.20 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.38 | 52 Week High | $ | |||
| Open | $84.01 | 52 Week Low | $ | |||
| Day High | $87.10 | P/E | N/A | |||
| Day Low | $83.41 | EPS | $ | |||
| Volume | 586,595 | |||||

